Sinovac Biotech Ltd (SVA)
6.47
0.00 (0.00%)
USD |
NASDAQ |
Apr 25, 16:00
Sinovac Biotech SG&A Expense (Quarterly)
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2020 | 83.05M |
| September 30, 2020 | 47.23M |
| June 30, 2020 | 29.79M |
| March 31, 2020 | 16.46M |
| December 31, 2019 | 33.30M |
| September 30, 2019 | 34.40M |
| June 30, 2019 | 30.19M |
| March 31, 2019 | 23.58M |
| December 31, 2018 | 40.70M |
| September 30, 2018 | 28.48M |
| June 30, 2018 | 44.50M |
| March 31, 2018 | 23.33M |
| December 31, 2016 | 15.24M |
| September 30, 2016 | 12.28M |
| June 30, 2016 | 8.264M |
| March 31, 2016 | 6.20M |
| December 31, 2015 | 11.70M |
| September 30, 2015 | 9.959M |
| June 30, 2015 | 9.014M |
| March 31, 2015 | 6.807M |
| December 31, 2014 | 9.442M |
| September 30, 2014 | 8.515M |
| June 30, 2014 | 8.589M |
| March 31, 2014 | 7.792M |
| December 31, 2013 | 8.276M |
| Date | Value |
|---|---|
| September 30, 2013 | 9.392M |
| June 30, 2013 | 8.786M |
| March 31, 2013 | 7.136M |
| December 31, 2012 | 14.41M |
| September 30, 2012 | 7.845M |
| June 30, 2012 | 6.700M |
| March 31, 2012 | 4.320M |
| December 31, 2011 | 7.078M |
| September 30, 2011 | 7.644M |
| June 30, 2011 | 4.979M |
| March 31, 2011 | 4.107M |
| December 31, 2010 | 7.374M |
| September 30, 2010 | 4.413M |
| June 30, 2010 | 3.992M |
| March 31, 2010 | 3.106M |
| December 31, 2009 | 6.237M |
| September 30, 2009 | 3.52M |
| June 30, 2009 | 4.860M |
| March 31, 2009 | 3.548M |
| December 31, 2008 | 3.904M |
| September 30, 2008 | 3.792M |
| June 30, 2008 | 6.039M |
| March 31, 2008 | 3.578M |
| December 31, 2007 | 2.472M |
| September 30, 2007 | 4.763M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
16.46M
Minimum
Mar 2020
83.05M
Maximum
Dec 2020
39.20M
Average
33.30M
Median
Dec 2019
SG&A Expense (Quarterly) Benchmarks
| CASI Pharmaceuticals Inc | 11.57M |
| Zai Lab Ltd | 82.63M |
| I-MAB | -- |
| Gracell Biotechnologies Inc (DELISTED) | 4.381M |
| Adagene Inc | -- |